Research

MaxiMoM

DoMINO trial

DoMINO

Donor Milk for Improved Neurodevelop-mental Outcomes

Key findings:

Donor milk does not improve neurodevelopment above preterm formula, but it reduces the risk of a serious bowel disease called necrotizing enterocolitis.

Donor milk and preterm formula result in similar growth at 5.5 years of age for children born very low birth weight (VLBW).

There is no difference in cost between donor milk and preterm formula to the healthcare system or families.

Preterm infants fed mother's own milk develop unique gut microbiotas.

OptiMoM trial

OptiMoM

Optimizing Mothers' Milk for Preterm Infants

Key findings:

Human milk-based fortifier does not improve feeding tolerance above bovine milk-based fortifier.

Human milk-based fortifier does not improve neurodevelopment above bovine milk-based fortifier.

Each mother of preterm infants has a unique milk microbiota and it changes over time.

MaxiMoM trial

MaxiMoM

Maximizing Mothers' Milk for Preterm Infants

Key findings:

Stay tuned!

Publications

Latest publications

Unger S, Christie-Holmes N, Guvenc F, Budylowski P, Mubareka S, Gray-Owen SD, O’Connor DL. Holder pasteurization of donated human milk is effective in inactivating SARS-CoV-2. CMAJ. 2020.

McGee M, Unger S, Hamilton J, Birken CS, Pausova Z, Vanderloo LM, Bando N, O’Connor DL. Lean mass accretion in children born very low birth weight is significantly associated with estimated changes from sedentary time to light physical activity. Pediatr Obes. 2020.

McGee M, Unger S, Hamilton J, Birken CS, Pausova Z, Kiss A, Bando N, O’Connor DL. Adiposity and fat-free mass of children born with very low birth weight do not differ in children fed supplemental donor milk compared with those fed preterm formula. J Nutr. 2019.

View all publications

Current studies